BioPharma Dive - Latest News

First Prader-Willi drug to reduce hunger approved by FDA

Clearance of Vykat unlocks what analysts anticipate will be a lucrative market opportunity for Soleno Therapeutics.

Mar 26, 2025 - 22:17
 0
First Prader-Willi drug to reduce hunger approved by FDA

Clearance of Vykat unlocks what analysts anticipate will be a lucrative market opportunity for Soleno Therapeutics.

Read More

Tags:

Previous Article

Drugmakers fear Trump 2.0 tariffs will drive up manufacturing costs, hurt medici...

Next Article

Salomon names Nick Parkinson as global brand creative director

Related Posts

Merck bets $200M on a new type of heart pill

Merck bets $200M on a new type of heart pill

Mar 25, 2025  0

Neumora bids farewell to R&D head; Biohaven’s ‘one step forward, one step back’ data

Neumora bids farewell to R&D head; Biohaven’s ‘one step...

Mar 4, 2025  0

Mineralys shares climb on study data for blood pressure drug

Mineralys shares climb on study data for blood pressure...

Mar 10, 2025  0